ADVANCED OVARIAN CANCER
Clinical trials for ADVANCED OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OVARIAN CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New IgE antibody trial targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called MOv18 IgE in people with advanced ovarian, endometrial, or triple-negative breast cancers that have a specific marker (folate receptor alpha). The study has two parts: first, finding a safe dose, and then checking how well that dose …
Matched conditions: ADVANCED OVARIAN CANCER
Phase: PHASE1 • Sponsor: Epsilogen Ltd • Aim: Disease control
Last updated May 26, 2026 11:35 UTC
-
New drug trial hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called BMS-986500 in people with advanced solid tumors or breast cancer that has stopped responding to standard treatments. The goal is to see if the drug is safe and how the body processes it. About 234 adults will take part, receiving the…
Matched conditions: ADVANCED OVARIAN CANCER
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 11:26 UTC